5 November 2020 - Pharma may have avoided a worst case scenario amid the political upheavals in the US elections with the threat of tough drug price legislation lowered, with hawkish Democrats unlikely to win overall control of Congress.

With the outcome of the presidential race unclear at the time of writing, Democrats likely to back tough drug pricing legislation may not have won the majority needed to control the Senate, although they look to have maintained control of the lower House of Representatives.

Read Pharmaphorum article